Stepan (SCL) Earnings Date & Reports

Key Takeaways

• Net sales rose 17% year over year to $692.2 million, driven by volume growth across all three operating segments.
• Reported net income increased 64% to $17.8 million, or $0.78 per diluted share, up from $0.47 in the prior-year quarter.
• Adjusted earnings per diluted share (EPS) jumped 98% to $0.94, comfortably above the roughly $0.73 consensus estimate.
• Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) climbed 18% to $66.3 million on surfactant margin recovery.
• Results included a $5.6 million pre-tax restructuring charge tied to the company's Project Catalyst cost program.
• Stepan raised its quarterly dividend by 2.5%, marking a 59th consecutive year of dividend increases.
• For more detail on Stepan's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated ticker pages.
• Discover automated trading ideas and signals by exploring Trending AI Robots.

Earnings Context and Why It Matters

Stepan Company's third quarter 2026 report carries weight because it signals whether the specialty and intermediate chemicals maker can sustain the momentum it has built in a volatile raw-material environment. The quarter tested the company's ability to pass through higher feedstock costs while still expanding volumes and recovering margins in its largest business, surfactants. Coming after a second quarter in which adjusted EPS of $1.18 far exceeded expectations, investors were watching for confirmation that the recovery was durable rather than a one-time event. The results also offer a read on demand across consumer cleaning, construction, and industrial end markets, making the report a useful gauge of broader manufacturing and consumer activity.

Reported Results

Stepan reported third quarter 2026 net sales of $692.2 million, a 17% increase from $590.3 million a year earlier, surpassing the consensus estimate of roughly $634.3 million. Reported net income rose 64% to $17.8 million, or $0.78 per diluted share, compared with $10.8 million, or $0.47 per diluted share, in the prior-year period.

On an adjusted basis, which excludes non-operational deferred compensation, environmental remediation costs, and restructuring items, net income climbed 98% to $21.7 million, or $0.94 per diluted share, up from $10.9 million, or $0.48 per diluted share. Adjusted EBITDA increased 18% to $66.3 million. Operating income rose 19% to $26.0 million.

By segment, Surfactants net sales increased 15% to about $486.6 million, Polymers sales rose 24% to about $178.7 million, and Specialty Products sales grew 12% to about $26.9 million. Reported results included a $5.6 million pre-tax restructuring charge related to Project Catalyst, the company's plan to optimize its asset base and organization.

AI Screener

Tickeron's AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener helps identify trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. For investors tracking specialty chemical peers or sector-wide momentum following an earnings report like Stepan's, the tool offers a structured way to surface comparable opportunities.

Market Reaction and Investor Sentiment

Heading into the report, sentiment around Stepan had been constructive after a series of earnings beats, though the specialty chemicals sector faced ongoing concern about raw-material inflation and supply-chain disruption tied to Middle East conflict. The third quarter results generally reinforced the positive narrative: revenue and adjusted EPS both came in ahead of consensus, and management highlighted broad-based organic volume growth of 7% across all three segments. The $5.6 million restructuring charge was largely expected as part of Project Catalyst, limiting its impact on investor interpretation. Focus on the earnings call centered on margin recovery, pricing discipline, and progress in deleveraging, with net leverage improving to 2.4 times from 2.7 times a year ago.

Forward Outlook and Key Factors to Monitor

Looking ahead, investors should monitor several themes that management emphasized on the earnings call. First is the trajectory of Project Catalyst savings, where Stepan now expects to exceed its 60% two-year, $100 million pre-tax savings target for 2026, with a run rate of approximately $23 million per quarter in the third quarter. Continued execution here could support margin expansion even amid inflation.

Second, raw-material costs remain volatile, partly due to Middle East conflict. Stepan's dual petrochemical and oleochemical feedstock flexibility and its contractual pass-through mechanisms have so far offset higher costs, but sustained input inflation would remain a key risk to watch.

Third, balance-sheet progress matters. Free cash flow was positive at $8 million despite a working-capital build, and the October sale of a land parcel near the Millsdale site for $28.5 million is earmarked to reduce debt. Further deleveraging, continued dividend growth, and any update to full-year adjusted EBITDA and cash-flow expectations will likely shape how the market assesses the stock in the quarters ahead.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations